Loading clinical trials...
Loading clinical trials...
A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S6G5T-3 in the Treatment of Acne Vulgaris
Conditions
Interventions
S6G5T-3
S6G5T-8
Locations
1
United States
Sol-Gel site 501
Tampa, Florida, United States
Start Date
December 14, 2018
Primary Completion Date
October 23, 2019
Completion Date
October 23, 2019
Last Updated
December 16, 2021
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT07348978
Lead Sponsor
Sol-Gel Technologies, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions